185 related articles for article (PubMed ID: 23873636)
1. P2X1 receptor-mediated inhibition of the proliferation of human coronary smooth muscle cells involving the transcription factor NR4A1.
Hinze AV; Mayer P; Harst A; von Kügelgen I
Purinergic Signal; 2013 Dec; 9(4):677-86. PubMed ID: 23873636
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A(3) receptor-induced proliferation of primary human coronary smooth muscle cells involving the induction of early growth response genes.
Hinze AV; Mayer P; Harst A; von Kügelgen I
J Mol Cell Cardiol; 2012 Nov; 53(5):639-45. PubMed ID: 22906537
[TBL] [Abstract][Full Text] [Related]
3. NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors.
Braun K; Rettinger J; Ganso M; Kassack M; Hildebrandt C; Ullmann H; Nickel P; Schmalzing G; Lambrecht G
Naunyn Schmiedebergs Arch Pharmacol; 2001 Sep; 364(3):285-90. PubMed ID: 11521173
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt].
Hechler B; Magnenat S; Zighetti ML; Kassack MU; Ullmann H; Cazenave JP; Evans R; Cattaneo M; Gachet C
J Pharmacol Exp Ther; 2005 Jul; 314(1):232-43. PubMed ID: 15792995
[TBL] [Abstract][Full Text] [Related]
5. Identification of atropine- and P2X1 receptor antagonist-resistant, neurogenic contractions of the urinary bladder.
Kennedy C; Tasker PN; Gallacher G; Westfall TD
J Neurosci; 2007 Jan; 27(4):845-51. PubMed ID: 17251425
[TBL] [Abstract][Full Text] [Related]
6. Impaired P2X1 Receptor-Mediated Adhesion in Eosinophils from Asthmatic Patients.
Wright A; Mahaut-Smith M; Symon F; Sylvius N; Ran S; Bafadhel M; Muessel M; Bradding P; Wardlaw A; Vial C
J Immunol; 2016 Jun; 196(12):4877-84. PubMed ID: 27183585
[TBL] [Abstract][Full Text] [Related]
7. Activation of Prejunctional P2x2/3 Heterotrimers by ATP Enhances the Cholinergic Tone in Obstructed Human Urinary Bladders.
Silva-Ramos M; Silva I; Faria M; Ferreirinha F; Correia-de-Sá P
J Pharmacol Exp Ther; 2020 Jan; 372(1):63-72. PubMed ID: 31636173
[TBL] [Abstract][Full Text] [Related]
8. Molecular identification of P2X receptors in vascular smooth muscle cells from rat anterior, posterior, and basilar arteries.
Harhun MI; Sukhanova K; Gordienko D; Dyskina Y
Pharmacol Rep; 2015 Dec; 67(6):1055-60. PubMed ID: 26481522
[TBL] [Abstract][Full Text] [Related]
9. Vascular smooth muscle cells from small human omental arteries express P2X1 and P2X4 receptor subunits.
Nichols CM; Povstyan OV; Albert AP; Gordienko DV; Khan O; Vasilikostas G; Khong TK; Wan A; Reddy M; Harhun MI
Purinergic Signal; 2014 Dec; 10(4):565-72. PubMed ID: 24845338
[TBL] [Abstract][Full Text] [Related]
10. Use of chimeras, point mutants, and molecular modeling to map the antagonist-binding site of 4,4',4″,4‴-(carbonylbis-(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakisbenzene-1,3-disulfonic acid (NF449) at P2X1 receptors for ATP.
Farmer LK; Schmid R; Evans RJ
J Biol Chem; 2015 Jan; 290(3):1559-69. PubMed ID: 25425641
[TBL] [Abstract][Full Text] [Related]
11. A₂B receptors mediate the induction of early genes and inhibition of arterial smooth muscle cell proliferation via Epac.
Mayer P; Hinze AV; Harst A; von Kügelgen I
Cardiovasc Res; 2011 Apr; 90(1):148-56. PubMed ID: 21109603
[TBL] [Abstract][Full Text] [Related]
12. Ectodomain lysines and suramin block of P2X1 receptors.
Sim JA; Broomhead HE; North RA
J Biol Chem; 2008 Oct; 283(44):29841-6. PubMed ID: 18765669
[TBL] [Abstract][Full Text] [Related]
13. P2X1 receptor-mediated vasoconstriction of afferent arterioles in angiotensin II-infused hypertensive rats fed a high-salt diet.
Inscho EW; Cook AK; Clarke A; Zhang S; Guan Z
Hypertension; 2011 Apr; 57(4):780-7. PubMed ID: 21321307
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the binding characteristics of recombinant P2X1 and P2X2 purinoceptors.
Michel AD; Lundström K; Buell GN; Surprenant A; Valera S; Humphrey PP
Br J Pharmacol; 1996 Aug; 118(7):1806-12. PubMed ID: 8842447
[TBL] [Abstract][Full Text] [Related]
15. A fluorescent approach for identifying P2X1 ligands.
Ruepp MD; Brozik JA; de Esch IJ; Farndale RW; Murrell-Lagnado RD; Thompson AJ
Neuropharmacology; 2015 Nov; 98():13-21. PubMed ID: 26026951
[TBL] [Abstract][Full Text] [Related]
16. P2X1 receptors localized in lipid rafts mediate ATP motor responses in the human vas deferens longitudinal muscles.
Donoso MV; Norambuena A; Navarrete C; Poblete I; Velasco A; Huidobro-Toro JP
Biol Reprod; 2014 Feb; 90(2):23. PubMed ID: 24352557
[TBL] [Abstract][Full Text] [Related]
17. Congestive heart failure induces downregulation of P2X1-receptors in resistance arteries.
Malmsjö M; Bergdahl A; Möller S; Zhao XH; Sun XY; Hedner T; Edvinsson L; Erlinge D
Cardiovasc Res; 1999 Jul; 43(1):219-27. PubMed ID: 10536707
[TBL] [Abstract][Full Text] [Related]
18. Smooth muscle does not have a common P2x receptor phenotype: expression, ontogeny and function of P2x1 receptors in mouse ileum, bladder and reproductive systems.
Vial C; Evans RJ
Auton Neurosci; 2001 Sep; 92(1-2):56-64. PubMed ID: 11570704
[TBL] [Abstract][Full Text] [Related]
19. NF449, a novel picomolar potency antagonist at human P2X1 receptors.
Hülsmann M; Nickel P; Kassack M; Schmalzing G; Lambrecht G; Markwardt F
Eur J Pharmacol; 2003 May; 470(1-2):1-7. PubMed ID: 12787824
[TBL] [Abstract][Full Text] [Related]
20. Electrical properties of purinergic transmission in smooth muscle of the guinea-pig prostate.
Lam M; Mitsui R; Hashitani H
Auton Neurosci; 2016 Jan; 194():8-16. PubMed ID: 26657181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
